 | |
- close
- close
|
Business Wire
Nov 11
Comment
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Lazard
newratings.com
Nov 6
Comment
NEW YORK, November 5 (newratings.com) - Analysts at Robert W Baird upgrade Synta Pharma (ticker: SNTA) from "hold" to "buy." The target price has been raised from $2 to $4. [more]
StreetInsider.com
Nov 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Roth+Capital+Upgrades+Synta+Pharmaceuticals+%28SNTA%29+to+Buy/5078030.html for the full story.
Business Wire
Nov 4
Comment
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended September
Business Wire
Oct 22
Comment
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced it will release its third-quarter 2009 financial
Business Wire
Sep 29
Comment
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study
Business Wire
Sep 3
Comment
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the R.W.
TheStreet.com
Aug 11
Comment
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
SNTA AT A GLANCE
References
| ||||||
|
|
